These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20338236)

  • 1. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.
    Stack C; Ho D; Wille E; Calingasan NY; Williams C; Liby K; Sporn M; Dumont M; Beal MF
    Free Radic Biol Med; 2010 Jul; 49(2):147-58. PubMed ID: 20338236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nrf2 pathway as a potential therapeutic target for Huntington disease A commentary on "Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington disease".
    Escartin C; Brouillet E
    Free Radic Biol Med; 2010 Jul; 49(2):144-6. PubMed ID: 20399852
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis.
    Neymotin A; Calingasan NY; Wille E; Naseri N; Petri S; Damiano M; Liby KT; Risingsong R; Sporn M; Beal MF; Kiaei M
    Free Radic Biol Med; 2011 Jul; 51(1):88-96. PubMed ID: 21457778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
    Pitha-Rowe I; Liby K; Royce D; Sporn M
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5339-47. PubMed ID: 19494206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.
    Yang L; Calingasan NY; Thomas B; Chaturvedi RK; Kiaei M; Wille EJ; Liby KT; Williams C; Royce D; Risingsong R; Musiek ES; Morrow JD; Sporn M; Beal MF
    PLoS One; 2009 Jun; 4(6):e5757. PubMed ID: 19484125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity.
    Casares L; Moreno R; Ali KX; Higgins M; Dayalan Naidu S; Neill G; Cassin L; Kiib AE; Svenningsen EB; Minassi A; Honda T; Poulsen TB; Wiel C; Sayin VI; Dinkova-Kostova AT; Olagnier D; de la Vega L
    Redox Biol; 2022 May; 51():102291. PubMed ID: 35313207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
    Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
    Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
    Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
    Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
    Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
    Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
    Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
    Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
    Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDDO-9,11-dihydro-trifluoroethyl amide (CDDO-dhTFEA) induces hepatic cytoprotective genes and increases bile flow in rats.
    Reisman SA; Ward KW; Klaassen CD; Meyer CJ
    Xenobiotica; 2013 Jul; 43(7):571-8. PubMed ID: 23244591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
    Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J
    Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion.
    Xu Z; Cho H; Hartsock MJ; Mitchell KL; Gong J; Wu L; Wei Y; Wang S; Thimmulappa RK; Sporn MB; Biswal S; Welsbie DS; Duh EJ
    J Neurochem; 2015 Apr; 133(2):233-41. PubMed ID: 25683606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
    Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
    J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic preconditioning provides long-lasting neuroprotection against ischemic stroke: The role of Nrf2.
    Yang T; Sun Y; Li Q; Li S; Shi Y; Leak RK; Chen J; Zhang F
    Exp Neurol; 2020 Mar; 325():113142. PubMed ID: 31812555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of CDDO-ethyl amide against high-glucose-induced oxidative injury via the Nrf2/HO-1 pathway.
    Zhang CX; Wang T; Ma JF; Liu Y; Zhou ZG; Wang DC
    Spine J; 2017 Jul; 17(7):1017-1025. PubMed ID: 28343048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel Nrf2 activator CDDO-EA attenuates cerebral ischemic injury by promoting microglia/macrophage polarization toward M2 phenotype in mice.
    Lei X; Li H; Li M; Dong Q; Zhao H; Zhang Z; Sun B; Mao L
    CNS Neurosci Ther; 2021 Jan; 27(1):82-91. PubMed ID: 33280237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Nrf2 in Astrocytes Suppressed PD-Like Phenotypes via Antioxidant and Autophagy Pathways in Rat and Drosophila Models.
    Guo Q; Wang B; Wang X; Smith WW; Zhu Y; Liu Z
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.